The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Melanoma Thickness and Survival Trends in the United States, 1989–2009
Open accessAbstract
BACKGROUND: With melanoma incidence rising and mortality stable, some question whether the melanoma epidemic is real. Melanoma thickness and survival trends may provide insights, but previous studies have been limited because of missing data on thickness. METHODS: With a validated imputation method for missing thickness data, we characterized melanoma thickness and survival trends among men and women in the Surveillance, Epidemiology, and End Results (SEER)-9 registries between 1989 and 2009. A total of 98,498 cases of invasive melanoma were identified. All statistical tests were two-sided. RESULTS: Incidence per 100 000 person-years increased (13.94, 95% confidence interval [CI] = 13.65 to 14.23, to 21.87, 95% CI = 21.56 to 22.19, P < .001) between 1989 to 1991 and 2007 to 2009, fatal incidence remained stable (2.32, 95% CI = 2.2 to 2.4, to 2.08, 95% CI = 2.0 to 2.2, P = .20) between 1989 to 1991 and 1998 to 2000, and five-year survival increased (88.29%, 95% CI = 87.60% to 88.95%, to 91.68%, 95% CI = 91.22% to 92.12%, P < .001) between 1989 to 1991 and 2001 to 2003. Increase in incidence occurred across all thickness groups. Median thickness decreased (0.73 to 0.58mm). Geometric mean thickness decreased (0.77 to 0.65mm) 4.6% (95% CI = 4.2% to 5.0%) every three years in multivariable analysis. Thickness decreased among T1/T2 tumors (0.01-1.00 and 1.01-2.00mm) and among all age and sex groups, whites, non-Hispanics, and all body sites. However, thickness increased among T3/T4 tumors (2.01-4.00 and > 4.00mm) and nodular melanomas; acral lentiginous melanomas approached statistical significance. Thickness remained unchanged among some racial minorities. Melanoma-specific survival improved (hazard ratio [HR] = 0.89, 95% CI = 0.88 to 0.91) every three years in multivariable analysis. Improvements in survival occurred across all subgroups except nonblack minorities, and nodular and acral lentiginous subtypes. CONCLUSIONS: Increasing incidence across all thickness groups coupled with T3/T4 lesions becoming thicker suggests that the melanoma epidemic is real and not simply an artifact of increased detection pressure of earlier-stage T1/T2 lesions. Survival is generally improving independent of thickness, but improvements in survival have not been experienced by certain minorities, and nodular and acral lentiginous subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Jemal, A., Saraiya, M., Patel, P., Cherala, S. S., Barnholtz-Sloan, J., Kim, J., Wiggins, C. L., & Wingo, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.032 · Cited by 385
Zell, J. A., Cinar, P., Mobasher, M., Ziogas, A., Meyskens, F. L., & Anton-Culver, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3604 · Cited by 176
Cited by
Estimated Projection of US Cancer Incidence and Death to 2040
Rahib, L., Wehner, M. R., Matrisian, L. M., & Nead, K. T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.4708 · Cited by 1,339
Epidemiological trends in skin cancer
Apalla, Z., Lallas, A., Sotiriou, E., Lazaridou, E., & Ioannides, D. (2017) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0702a01 · Cited by 628
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Apalla, Z., Nashan, D., Weller, R. B., & Castellsagué, X. (2017) · Dermatology and Therapy · doi:10.1007/s13555-016-0165-y · Cited by 465
Epidemiology and Risk Factors of Melanoma
Carr, S., Smith, C., & Wernberg, J. (2020) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.09.005 · Cited by 360
Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma
Lee, H. J., Chen, Z., Collard, M., Chen, F., Chen, J. G., Wu, M., Alani, R. M., & Cheng, J.-X. (2021) · BME Frontiers · doi:10.34133/2021/9860123 · Cited by 38
Metadata
- Authors
- Shaikh, W. R., Dusza, S. W., Weinstock, M. A., Oliveria, S. A., Geller, A. C., & Halpern, A. C.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-12
- Volume
- 108
- Issue
- 1
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2237180596
- Cited by
- 169
- References
- 2
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melanoma Thickness and Survival Trends in the United States, 1989–2009. https://app.cochat.ai/papers/10.1093/jnci/djv294
- The paper
- Shaikh, W. R., Dusza, S. W., Weinstock, M. A., Oliveria, S. A., Geller, A. C., & Halpern, A. C. (2016). Melanoma Thickness and Survival Trends in the United States, 1989–2009. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djv294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.